Cargando…
Efficacy of combined tumor irradiation and K(Ca)3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
The intermediate-conductance calcium-activated potassium channel K(Ca)3.1 has been proposed to be a new potential target for glioblastoma treatment. This study analyzed the effect of combined irradiation and K(Ca)3.1-targeting with TRAM-34 in the syngeneic, immune-competent orthotopic SMA-560/VM/Dk...
Autores principales: | Stransky, Nicolai, Ganser, Katrin, Quintanilla-Martinez, Leticia, Gonzalez-Menendez, Irene, Naumann, Ulrike, Eckert, Franziska, Koch, Pierre, Huber, Stephan M., Ruth, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667541/ https://www.ncbi.nlm.nih.gov/pubmed/37996600 http://dx.doi.org/10.1038/s41598-023-47552-4 |
Ejemplares similares
-
Tumoricidal, Temozolomide- and Radiation-Sensitizing Effects of K(Ca)3.1 K(+) Channel Targeting In Vitro Are Dependent on Glioma Cell Line and Stem Cell Fraction
por: Stransky, Nicolai, et al.
Publicado: (2022) -
Ion channels as molecular targets of glioblastoma electrotherapy
por: Abed, Tayeb, et al.
Publicado: (2023) -
Against Repurposing Methadone for Glioblastoma Therapy
por: Vatter, Tatjana, et al.
Publicado: (2020) -
Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34
por: Naziris, Nikolaos, et al.
Publicado: (2021) -
Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study
por: Zirjacks, Lisa, et al.
Publicado: (2021)